The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study

Torsten Dahlén^{1

2}, Hjalmar Flygt³, Anna Lübking⁴, Ulla Olsson-Strömberg³, Lovisa Wennström⁵, Arta Dreimane⁶, Anders Själander⁷, Susannah Leach^{8

9}, Magnus Gisslén^{10

11}, Huiqi Li¹², Martin Höglund³, Leif Stenke¹³, Fredrik Nyberg¹²

Affiliations

¹ Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden. torsten.dahlen@ki.se.
² Department of Hematology, Karolinska University Hospital, Stockholm, Sweden. torsten.dahlen@ki.se.
³ Department of Medical Science and Division of Hematology, University Hospital, Uppsala, Sweden.
⁴ Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
⁵ Section of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
⁶ Department of Hematology, Linköping University Hospital, Linköping, Sweden.
⁷ Department of Public Health and Clinical Medicine, Umeå University, Sundsvall, Sweden.
⁸ Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
⁹ Department of Microbiology and Immunology, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
¹⁰ Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
¹¹ Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
¹² School of Public health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
¹³ Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.

Torsten Dahlén et al. Leukemia. 2023 May.

. 2023 May;37(5):1156-1159.

doi: 10.1038/s41375-023-01893-1. Epub 2023 Apr 10.

¹ Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden. torsten.dahlen@ki.se.
² Department of Hematology, Karolinska University Hospital, Stockholm, Sweden. torsten.dahlen@ki.se.
³ Department of Medical Science and Division of Hematology, University Hospital, Uppsala, Sweden.
⁴ Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
⁵ Section of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
⁶ Department of Hematology, Linköping University Hospital, Linköping, Sweden.
⁷ Department of Public Health and Clinical Medicine, Umeå University, Sundsvall, Sweden.
⁸ Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
⁹ Department of Microbiology and Immunology, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
¹⁰ Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
¹¹ Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
¹² School of Public health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
¹³ Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Conflict of interest statement

Outside the scope of this work, Dr. Dahlén reports funding from Novartis and Dr. Stenke from Xspray.

1. WHO. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ (accessed Nov 2022).
1. Langerbeins P, Hallek M. COVID-19 in patients with hematologic malignancy. Blood. 2022;140:236–52. doi: 10.1182/blood.2021012251. - DOI - PMC - PubMed
1. Li W, Wang D, Guo J, Yuan G, Yang Z, Gale RP, et al. COVID-19 in persons with chronic myeloid leukemia. Leukemia. 2020;34:1799–804. doi: 10.1038/s41375-020-0853-6. - DOI - PMC - PubMed
1. Pagnano KB, Kok CH, Mauro MJ, Cortes JE, Evans N, Jiang Q, et al. COVID-19 in patients with chronic myeloid leukemia: poor outcomes for patients with comorbidities, older age, advanced phase disease, and those from low-income countries: an update of the candid study. Blood. 2021;138:634. doi: 10.1182/blood-2021-150026. - DOI
1. Breccia M, Abruzzese E, Accurso V, Attolico I, Barulli S, Bergamaschi M, et al. COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. Brit J Haematol. 2022;196:559–65. doi: 10.1111/bjh.17890. - DOI - PMC - PubMed